Lessee, Operating Lease, Liability, to be Paid, Year One in USD of Lexaria Bioscience Corp. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Lexaria Bioscience Corp. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and change rate from Q3 2020 to Q3 2025.
  • Lexaria Bioscience Corp. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending 31 Aug 2025 was $38.6K.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $38.6K +$38.6K 31 Aug 2025 10-K 28 Nov 2025
Q2 2025 $37.3K +$28.4K +317% 31 May 2025 10-Q 14 Jul 2025
Q1 2025 $37.3K +$19.4K +108% 28 Feb 2025 10-Q 14 Apr 2025
Q4 2024 $0 -$26.9K -100% 30 Nov 2024 10-Q 10 Jan 2025
Q3 2024 $0 -$35.8K -100% 31 Aug 2024 10-K 26 Nov 2024
Q2 2024 $8.96K 31 May 2024 10-Q 12 Jul 2024
Q1 2024 $17.9K -$17.9K -50% 29 Feb 2024 10-Q 09 Apr 2024
Q4 2023 $26.9K -$6.73K -20% 30 Nov 2023 10-Q 12 Jan 2024
Q3 2023 $35.8K 31 Aug 2023 10-K 20 Nov 2023
Q1 2023 $35.8K 31 Mar 2023 10-Q 14 Jul 2023
Q4 2022 $33.6K 30 Nov 2022 10-Q/A 18 Jan 2023
Q2 2022 $44.8K +$33.8K +308% 31 May 2022 10-K 28 Nov 2022
Q2 2021 $11K 31 May 2021 10-Q 15 Jul 2021
Q1 2021 $22K 28 Feb 2021 10-Q 14 Apr 2021
Q4 2020 $32.7K 30 Nov 2020 10-Q 14 Jan 2021
Q3 2020 $44K 31 Aug 2020 10-K 15 Oct 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.